UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A metagenomic framework for the study of airborne microbial communities

PloS one, 2013-12, Vol.8 (12), p.e81862

2013

Volltextzugriff (PDF)

Erythema and Induration after Mpox (JYNNEOS) Vaccination Revisited

The New England journal of medicine, 2023-04, Vol.388 (15), p.1432-1435

2023

Volltextzugriff (PDF)

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

JAMA : the journal of the American Medical Association, 2014-05, Vol.311 (17), p.1760

2014

Volltextzugriff (PDF)

Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial

PloS one, 2017-01, Vol.12 (1), p.e0167488-e0167488

2017

Volltextzugriff (PDF)

Metabolic reconstruction for metagenomic data and its application to the human microbiome

PLoS computational biology, 2012-06, Vol.8 (6), p.e1002358-e1002358

2012

Volltextzugriff (PDF)

Distinct gene expression signatures comparing latent tuberculosis infection with different routes of Bacillus Calmette-Guérin vaccination

Nature communications, 2023-12, Vol.14 (1), p.8507-17, Article 8507

2023

Volltextzugriff (PDF)

Connecting biodiversity and potential functional role in modern euxinic environments by microbial metagenomics

The ISME Journal, 2015-07, Vol.9 (7), p.1648-1661

2015

Volltextzugriff (PDF)

Metabolomic Signatures Differentiate Immune Responses in Avian Influenza Vaccine Recipients

The Journal of infectious diseases, 2024-09, Vol.230 (3), p.716-725

2024

Volltextzugriff (PDF)

AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Human Peripheral Blood Mononuclear Cells

The Journal of infectious diseases, 2019-06, Vol.219 (11), p.1786-1798

2019

Volltextzugriff (PDF)

Molecular Evolution of Herpes Simplex Virus 2 Complete Genomes: Comparison between Primary and Recurrent Infections

Journal of virology, 2017-12, Vol.91 (23)

2017

Volltextzugriff (PDF)

Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo

The Journal of infectious diseases, 2024-05, Vol.229 (5), p.1498-1508

2024

Volltextzugriff (PDF)

A new reference implementation of the PSICQUIC web service

Nucleic acids research, 2013-07, Vol.41 (W1), p.W601-W606

2013

Volltextzugriff (PDF)

Cytomegalovirus Genetic Diversity Following Primary Infection

The Journal of infectious diseases, 2020-02, Vol.221 (5), p.715-720

2020

Volltextzugriff (PDF)

Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference Sequence

The Journal of molecular diagnostics : JMD, 2022-03, Vol.24 (3), p.219-223

2022

Volltextzugriff (PDF)

AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Human Peripheral Blood Mononuclear Cells

The Journal of infectious diseases, 2019-05, Vol.219 (11), p.1786-1798

2019

Volltextzugriff (PDF)

The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies

Frontiers in immunology, 2023-01, Vol.13, p.1093242-1093242

2023

Volltextzugriff (PDF)

Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies

Frontiers in immunology, 2023-02, Vol.14, p.1163550-1163550

2023

Volltextzugriff (PDF)

Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses

The Journal of infectious diseases, 2021-10, Vol.224 (8), p.1372-1382

2021

Volltextzugriff (PDF)

Phase II randomized, double-blinded comparison of a single high dose (5 × 108 TCID50 ) of modified vaccinia Ankara compared to a standard dose (1 × 108 TCID50 ) in healthy vaccinia-naïve individuals

Vaccine, 2014-05, Vol.32 (23), p.2732-2739

2014

Volltextzugriff (PDF)

Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals

Vaccine, 2014-05, Vol.32 (23), p.2732

2014

Volltextzugriff (PDF)

The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination

npj vaccines, 2022-08, Vol.7 (1), p.103-103, Article 103

2022

Volltextzugriff (PDF)

MPIDB: the microbial protein interaction database

Bioinformatics, 2008-08, Vol.24 (15), p.1743-1744

2008

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Englisch
(106)
Deutsch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A metagenomic framework for the study of airborne microbial communities

Erythema and Induration after Mpox (JYNNEOS) Vaccination Revisited

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial

Metabolic reconstruction for metagenomic data and its application to the human microbiome

Distinct gene expression signatures comparing latent tuberculosis infection with different routes of Bacillus Calmette-Guérin vaccination

Protein interaction data curation: the International Molecular Exchange (IMEx) consortium

Functional tradeoffs underpin salinity-driven divergence in microbial community composition

Connecting biodiversity and potential functional role in modern euxinic environments by microbial metagenomics

Metabolomic Signatures Differentiate Immune Responses in Avian Influenza Vaccine Recipients

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Human Peripheral Blood Mononuclear Cells

Molecular Evolution of Herpes Simplex Virus 2 Complete Genomes: Comparison between Primary and Recurrent Infections

Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo

A new reference implementation of the PSICQUIC web service

Cytomegalovirus Genetic Diversity Following Primary Infection

Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference Sequence

AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Human Peripheral Blood Mononuclear Cells

The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies

Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies

Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses

Phase II randomized, double-blinded comparison of a single high dose (5 × 108 TCID50 ) of modified vaccinia Ankara compared to a standard dose (1 × 108 TCID50 ) in healthy vaccinia-naïve individuals

Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals

The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination

MPIDB: the microbial protein interaction database

Suchergebnisse filtern